Eli Lilly
LLY
$726.31
Share price
-2.63%
Change (1 day)
96.05%
Change (1 year)
Categories
With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.
Eli Lilly (LLY) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $53.14 B
According to Eli Lilly's latest financial reports the company's total liabilities are $53.14 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Eli Lilly - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $53.14 B | 37.27% |
| 2022-12-31 | $38.71 B | -2.36% |
| 2021-12-31 | $39.65 B | -2.83% |
| 2020-12-31 | $40.80 B | 11.54% |
| 2019-12-31 | $36.58 B | 10.87% |
| 2018-12-31 | $32.99 B | -0.94% |
| 2017-12-31 | $33.31 B | 34.73% |
| 2016-12-31 | $24.72 B | 17.86% |
| 2015-12-31 | $20.97 B | 0.28% |
| 2014-12-31 | $20.91 B | 18.81% |
| 2013-12-31 | $17.60 B | -10.28% |
| 2012-12-31 | $19.62 B | -2.48% |
| 2011-12-31 | $20.12 B | 8.26% |
| 2010-12-31 | $18.58 B | 3.64% |
| 2009-12-31 | $17.93 B | -20.2% |
| 2008-12-31 | $22.47 B | 68.09% |
| 2007-12-31 | $13.37 B | 21.83% |
| 2006-12-31 | $10.97 B | -20.41% |
| 2005-12-31 | $13.78 B | -1.13% |
| 2004-12-31 | $13.94 B | 16.97% |
| 2003-12-31 | $11.92 B | 10.73% |
| 2002-12-31 | $10.76 B | 15.42% |
| 2001-12-31 | $9.33 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 85.88% | 🇺🇸 USA |
 Novartis NVS | $53.19 B | 0.10% | 🇨🇭 Switzerland |
 Pfizer PFE | $137.21 B | 158.20% | 🇺🇸 USA |
 AbbVie ABBV | $124.31 B | 133.93% | 🇺🇸 USA |
 Amgen AMGN | $90.92 B | 71.09% | 🇺🇸 USA |
 Sanofi SNY | $57.61 B | 8.41% | 🇫🇷 France |
 Merck MRK | $69.04 B | 29.91% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $65.67 B | 23.58% | 🇺🇸 USA |
 AstraZeneca AZN | $61.95 B | 16.58% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $58.82 B | 10.69% | 🇬🇧 UK |